BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 566386)

  • 1. Enhanced NK cell activity in mice injected with interferon and interferon inducers.
    Gidlund M; Orn A; Wigzell H; Senik A; Gresser I
    Nature; 1978 Jun; 273(5665):759-61. PubMed ID: 566386
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of stimulation of natural killer-cell cytotoxicity by interferon and an interferon-inducer in the rat.
    Flexman JP; Shellam GR
    Immunology; 1981 Oct; 44(2):311-20. PubMed ID: 6170575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement by interferon of natural killer cell activity in mice.
    Senik A; Gresser I; Maury C; Gidlund M; Orn A; Wigzell H
    Cell Immunol; 1979 Apr; 44(1):186-200. PubMed ID: 313257
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement of mouse NK cells by interferon.
    Senik A; Gresser I; Maury C; Gidlund M; Orn A; Wigzell H
    Transplant Proc; 1979 Mar; 11(1):993-6. PubMed ID: 452109
    [No Abstract]   [Full Text] [Related]  

  • 5. Natural killer cells: characteristics and regulation of activity.
    Herberman RB; Djeu J; Kay HD; Ortaldo JR; Riccardi C; Bonnard GD; Holden HT; Fagnani R; Santoni A; Puccetti P
    Immunol Rev; 1979; 44():43-70. PubMed ID: 761939
    [No Abstract]   [Full Text] [Related]  

  • 6. Variation of interferon induction at the bone marrow level. Studies on interferon induction in relation to natural cell-mediated cytotoxic mechanisms.
    Orn A; Gidlund M; Wigzell H; Gresser I
    Eur J Immunol; 1981 Oct; 11(10):795-9. PubMed ID: 6171433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity.
    Herberman RB; Djeu JY; Ortaldo JR; Holden HT; West WH; Bonnard GD
    Cancer Treat Rep; 1978 Nov; 62(11):1893-6. PubMed ID: 728907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells.
    Lindahl P; Gresser I; Leary P; Tovey M
    Proc Natl Acad Sci U S A; 1976 Apr; 73(4):1284-7. PubMed ID: 1063409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-interferon globulin inhibits macrophage phagocytic enhancement in vivo by tilorone or Newcastle disease virus.
    Rabinovitch M; Manejias RE
    Cell Immunol; 1978 Sep; 39(2):402-6. PubMed ID: 699064
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoferon (AM3) enhances the activities of early-type interferon inducers and natural killer cells.
    Moya P; Baixeras E; Barasoain I; Rojo JM; Ronda E; Alonso ML; Portolés A
    Immunopharmacol Immunotoxicol; 1987; 9(2-3):243-56. PubMed ID: 2449486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of amyxin--a domestic analog of tilorone--on characteristics of interferon and immune status of man].
    Sel'kova EP; Semenenko TA; Nosik NN; Iudina TI; Amarian MP; Lavrukhina LA; Pantiukhova TN; Tarasova GIu
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (4):31-5. PubMed ID: 11569258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of activation of human natural killer cells against tumor and virus-infected cells.
    Santoli D; Koprowski H
    Immunol Rev; 1979; 44():125-163. PubMed ID: 153888
    [No Abstract]   [Full Text] [Related]  

  • 13. Natural killer cells do not belong to the recirculating lymphocyte population.
    Zöller M; Bellgrau D; Axberg I; Wigzell H
    Scand J Immunol; 1982 Feb; 15(2):159-67. PubMed ID: 6179152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interrelations of natural cellular cytotoxicity and interferon systems in immobilization stress].
    Sukhikh FT; Nosik NN; Parshina OV; Van'ko LV; Meerson FZ
    Biull Eksp Biol Med; 1984 Nov; 98(11):593-5. PubMed ID: 6210120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acting mechanisms of Lentinan in human--II. Enhancement of non-specific cell-mediated cytotoxicity as an interferon inducer.
    Miyakoshi H; Aoki T; Mizukoshi M
    Int J Immunopharmacol; 1984; 6(4):373-9. PubMed ID: 6207124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of interferon, macrophage, and lymphocyte tumoricidal activity with prostaglandin effect.
    Chirigos MA; Schultz RM; Stylos WA
    Ann N Y Acad Sci; 1980; 350():91-101. PubMed ID: 6165308
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancement by interferon of chicken splenocyte natural killer cell activity against Marek's disease tumor cells.
    Ding AH; Lam KM
    Vet Immunol Immunopathol; 1986 Jan; 11(1):65-72. PubMed ID: 2420060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The immunostimulating action of lactobacteria on the cytotoxicity of natural killer cells and interferon production].
    Tsoĭ IG; Saparov AS; Timofeeva IK; Dzhumagulova AB; Bulegenova MG; Seksenbaev BD
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):112-3. PubMed ID: 7533464
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory effect of interferon preparations and inducers on the multiplication of transplanted allogeneic spleen cells and syngeneic bone marrow cells.
    Cerottini JC; Brunner KT; Lindahl P; Gresser I
    Nat New Biol; 1973 Apr; 242(118):152-3. PubMed ID: 4573479
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased spreading of macrophages from mice treated with interferon inducers.
    Rabinovitch M; Manejias RE; Russo M; Abbey EE
    Cell Immunol; 1977 Mar; 29(1):86-95. PubMed ID: 849607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.